The Effect of VPA Treatment on Radiolabeled DOTATATE Uptake:Differences Observed In Vitro and In Vivo
In: Klomp , M J , Hofland , L J , van den Brink , L , van Koetsveld , P M , Dogan , F , de Ridder , C M A , Stuurman , D C , Clahsen-Van Groningen , M C , de Jong , M & Dalm , S U 2022 , ' The Effect of VPA Treatment on Radiolabeled DOTATATE Uptake : Differences Observed In Vitro and In Vivo ' , Pharmaceutics , vol. 14 , no. 1 , 173; (2022)
Online
Elektronische Ressource
Background: To improve peptide receptor radionuclide therapy (PRRT), we aimed to enhance the expression of somatostatin type-2 receptors (SSTR2) in vitro and in vivo, using valproic acid (VPA). Methods: Human NCI-H69 small-cell lung carcinoma cells were treated with VPA, followed by [111 In]In-DOTATATE uptake studies, RT-qPCR and immunohistochemistry analysis. Furthermore, NCI-H69 xenografted mice were treated with VPA or vehicle, followed by [177Lu]Lu-DOTATATE injection. Biodistribution studies were performed, and tissues were collected for further analysis. Results: VPA significantly increased SSTR2 expression in vitro. In animals, a statistically significant increased [177Lu]Lu-DOTATATE tumoral uptake was observed when VPA was administered eight hours before [177Lu]Lu-DOTATATE administration, but increased tumor SSTR2 expression levels were lacking. The animals also presented significantly higher [177Lu]Lu-DOTATATE blood levels, as well as an elevated renal tubular damage score. This suggests that the enhanced tumor uptake was presumably a consequence of the increased radiotracer circulation and the induced kidney damage. Conclusions: VPA increases SSTR2 expression in vitro. In vivo, the observed increase in tumoral [177Lu]Lu-DOTATATE uptake is not caused by SSTR2 upregulation, but rather by other mechanisms, e.g., an increased [177Lu]Lu-DOTATATE circulation time and renal toxicity. However, since both drugs are safely used in humans, the potential of VPA to improve PRRT remains open for investigation.
Titel: |
The Effect of VPA Treatment on Radiolabeled DOTATATE Uptake:Differences Observed In Vitro and In Vivo
|
---|---|
Link: | |
Quelle: | Klomp , M J , Hofland , L J , van den Brink , L , van Koetsveld , P M , Dogan , F , de Ridder , C M A , Stuurman , D C , Clahsen-Van Groningen , M C , de Jong , M & Dalm , S U 2022 , ' The Effect of VPA Treatment on Radiolabeled DOTATATE Uptake : Differences Observed In Vitro and In Vivo ' , Pharmaceutics , vol. 14 , no. 1 , 173; (2022) |
Veröffentlichung: | 2022 |
Medientyp: | Elektronische Ressource |
Schlagwort: |
|
Sonstiges: |
|